NewslettersCancer Stem Cell NewsPancreatic Cell News PharmaCyte Biotech Successfully Accelerates Development of Container Closure Integrity Test for Pancreatic Cancer Clinical Trial Product By Justin.choi - June 17, 2020 0 PharmaCyte Biotech, Inc. announced that it has successfully accelerated the development of its Container Closure Integrity test– an essential component of the Stability Test required by the FDA. [PharmaCyte Biotech Inc.] Press Release